Nektar Therapeutics (NKTR)
68.43
-1.33
(-1.91%)
USD |
NASDAQ |
Sep 14, 16:00
68.68
+0.25
(+0.37%)
After-Hours: 16:59
Nektar Therapeutics Market Cap : 2.335B for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.381B |
| September 10, 2026 | 2.411B |
| September 09, 2026 | 2.502B |
| September 08, 2026 | 2.575B |
| September 04, 2026 | 2.532B |
| September 03, 2026 | 2.606B |
| September 02, 2026 | 2.483B |
| September 01, 2026 | 2.449B |
| August 31, 2026 | 2.436B |
| August 28, 2026 | 2.475B |
| August 27, 2026 | 2.544B |
| August 26, 2026 | 2.518B |
| August 25, 2026 | 2.558B |
| August 24, 2026 | 2.515B |
| August 21, 2026 | 2.526B |
| August 20, 2026 | 2.544B |
| August 19, 2026 | 2.597B |
| August 18, 2026 | 2.513B |
| August 17, 2026 | 2.480B |
| August 14, 2026 | 2.492B |
| August 13, 2026 | 2.591B |
| August 12, 2026 | 2.595B |
| August 11, 2026 | 2.577B |
| August 10, 2026 | 1.526B |
| August 07, 2026 | 1.559B |
| Date | Value |
|---|---|
| August 06, 2026 | 1.497B |
| August 05, 2026 | 1.489B |
| August 04, 2026 | 1.483B |
| August 03, 2026 | 1.439B |
| July 31, 2026 | 1.440B |
| July 30, 2026 | 1.456B |
| July 29, 2026 | 1.440B |
| July 28, 2026 | 1.442B |
| July 27, 2026 | 1.454B |
| July 24, 2026 | 1.441B |
| July 23, 2026 | 1.413B |
| July 22, 2026 | 1.413B |
| July 21, 2026 | 1.399B |
| July 20, 2026 | 1.321B |
| July 17, 2026 | 1.391B |
| July 16, 2026 | 1.366B |
| July 15, 2026 | 1.392B |
| July 14, 2026 | 1.369B |
| July 13, 2026 | 1.392B |
| July 10, 2026 | 1.434B |
| July 09, 2026 | 1.486B |
| July 08, 2026 | 1.465B |
| July 07, 2026 | 1.526B |
| July 06, 2026 | 1.491B |
| July 02, 2026 | 1.448B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Elite Pharmaceuticals, Inc. | 283.29M |
| Daré Bioscience, Inc. | 11.14M |
| Aclaris Therapeutics, Inc. | 790.01M |
| Eton Pharmaceuticals, Inc. | 1.628B |
| Journey Medical Corp. | 204.66M |
Market Cap Related Metrics
| PS Ratio | 30.41 |
| PEG Ratio | -0.0762 |
| Price to Book Value | 2.586 |
| Price | 68.43 |
| Earnings Yield | -9.79% |
| PEGY Ratio | -0.0762 |